Cargando…
β-d-Glucan Testing Is Overused in Patients Without Solid Organ/Stem Cell Transplant or Hematologic Malignancies
BACKGROUND: The β-d-glucan (BDG) assay aids in diagnosis of some invasive fungal infections (IFI) in at-risk patients. Due to an increase in the number of BDG tests ordered at Johns Hopkins Hospital in patients not at high risk for IFI, we evaluated the appropriateness of testing and conducted a sur...
Autores principales: | Markou, Theodore, Fabre, Valeria, Mehta, Seema, Shoham, Shmuel, Cosgrove, Sara E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631691/ http://dx.doi.org/10.1093/ofid/ofx163.007 |
Ejemplares similares
-
Single Academic Center Experience of Unrestricted β-d-Glucan Implementation
por: Fabre, Valeria, et al.
Publicado: (2018) -
205. Rectal Stool Surveillance Cultures to Guide Empiric Antibiotic Therapy in Patients with Hematologic Malignancies with or without Hematopoietic Stem Cell Transplantation
por: Sait, Afrah S, et al.
Publicado: (2020) -
Nocardiosis and elevated beta-d-glucan in solid organ transplant recipients
por: Ringer, Matthew, et al.
Publicado: (2021) -
Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009) -
Risk of infection associated with targeted therapies for solid organ and hematological malignancies
por: Ruiz-Camps, Isabel, et al.
Publicado: (2021)